A Trial of Intravenous Denileukin Diftitox Plus Subcutaneous Pegylated IFNα-2A in Stage III or IV Ovarian Cancer
Clinical trial NCT01773889 · TERMINATED
Trial details
- NCT number
- NCT01773889
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2011-06-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.